Zoe Deol

Once her bariatric surgery patients lost weight, they sought to treat the varicose veins, heaviness, and fatigue in their legs, which hindered their ability to exercise and maintain their weight loss. Her prior residency training in vascular surgery provided the foundation for her transition into minimally invasive endovenous surgery. After leaving her private practice in to accept a position in Chicago, she later returned to Detroit, and devoted her entire career to the treatment of venous disease. Her return to Michigan coincided with the 2008 rescission, and Detroit was among the hardest-hit cities in the country. The plight of the autoworkers struck a cord with her, and she focused her efforts on providing them with the much-needed care for the many hours they worked standing on the line in the factories.

“Detroit was the backbone by which this country was supported for decades, and I saw her through one of the biggest blows since the depression. She is a city of hope and tenacity, and this is due entirely to its people. The autoworkers are the legs upon which this city stands. It is my personal passion to provide them, and all of the equally hard working residents of Detroit and the surrounding cities, the care they so rightfully deserve.”

Dr. Deol has become an integral part of the academic venous world, and was invited by the President of the American Vein and Lymphatic Society (AVLS) to serve as a representative of the United States on their International Committee. This position affords her the opportunity to fill a diplomatic role while staying abreast of the latest vein techniques being used around the world. Additionally, Dr. Deol accepted an invitation from another prestigious national organization, the American Venous Forum (AVF), to serve on their Website and Social Media Committee. Her role on that committee is to improve the organization’s capacity to educate the general public about venous disease. She is also a member of the American Medical Society (AMA), American College of Surgeons (ACS), the American Society of Bariatric and Metabolic Surgery (ASMBS), the American Professional Wound Care Association (APWCA), and the Michigan State Medical Society (MSMS).

Most recently, Dr. Deol conducted a case study on Varithena and how the treatment can resolve activity limiting symptoms after profound weight loss.